Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
08/2003
08/20/2003CN1118462C Substituted phenyl derivatives, producing method and use thereof
08/19/2003US6608120 Cyclopolymerized under the influence of ultraviolet or thermal radiation; coatings or binders
08/14/2003WO2003066583A1 Astaxanthin esters
08/14/2003WO2003066578A1 PROCESS FOR PRODUCING ß-HYDROXYAMINO ACID DERIVATIVE AND INTERMEDIATE THEREFOR
08/14/2003WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions
08/14/2003WO2003066549A2 Synthesis of sulfamidates
08/14/2003WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
08/14/2003WO2003060026A8 Water-soluble carbamate materials
08/14/2003WO2002070653A3 Peptide deformylase inhibitors
08/14/2003US20030153788 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/13/2003EP1334084A2 Phosgene-free process for preparing carbamates
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003CN1436168A Beta-amino acid nitrile derivs.
08/13/2003CN1435410A Fluorinated dihydric alcohol
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605625 Antiarrhythmia agents
08/07/2003WO2003064550A1 Waterborne coating compositions containing materials dispersed with water-soluble carbamate materials
08/07/2003WO2003064432A1 Process for total synthesis of ecteinascidins and intermediates therefor
08/07/2003US20030149104 Tri-substituted phenyl derivatives and analogues
08/07/2003CA2466254A1 Waterborne coating compositions containing materials dispersed with water-soluble carbamate materials
08/06/2003EP1333024A1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof
08/06/2003EP1084103B1 New 3-aryl-2-hydroxypropionic acid derivative (i)
08/06/2003EP0874800B1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity
08/06/2003EP0865419B1 Indane dimer compounds and their pharmaceutical use
08/06/2003CN1434046A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434044A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434043A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434037A Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/05/2003US6603046 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria.
08/05/2003US6603012 RAR selective retinoid agonists
08/05/2003US6602987 4'-hydroxyazobenzene-2-carboxylic acid (HABA) compounds; useful as reagents for labeling, isolation and detection of biological molecules
08/05/2003CA2092062C Peptide synthesis process and novel synthesis intermediates
07/2003
07/31/2003WO2003062192A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
07/31/2003WO2002062762A3 Potassium channel openers
07/31/2003US20030144542 Use of propargyl glycine amino propargyl diol compounds for treatment of renal failure
07/31/2003US20030144277 Piperizinones as modulators of chemokine receptor activity
07/31/2003US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis
07/31/2003US20030144253 Useful for treating or preventing neuronal damage associated with neurological diseases
07/31/2003US20030144214 Alkyl amino acid derivatives useful as pharmaceutical agents
07/31/2003US20030144186 Conformationally constrained backbone cyclized peptide analogs
07/31/2003US20030143559 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand
07/30/2003EP1330464A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
07/30/2003EP1330443A1 Substituted phenyluracils
07/30/2003EP0705100B1 Therapeutic substituted guanidines
07/30/2003CN1433401A New phenalkyloxy-phenyl derivatives
07/30/2003CN1432563A Prepn process of carbamate and prepn process of isocyanate
07/30/2003CN1116284C Process for preparation of alpha, alpha'-diaminoalcohol
07/29/2003US6600074 Perfluoroalkylated aniline compound and process for producing the same
07/29/2003US6600072 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic , and medicament containing them
07/29/2003US6600062 Enantioselectivity; epoxidizing and hydrolyzing the geranyloxy compound
07/29/2003US6600045 This invention relates to methods for preparing certain cholesteryl ester transfer protein (CETP) inhibitors and intermediates useful in the preparation of said CETP inhibitors.
07/29/2003US6599935 2-phenyl-1,3-propanediol dicarbamate derivatives used as antiepileptic and antiischemic agents
07/29/2003US6599754 Semipermeable membrane separating the contents of the first chamber from the contents of the second chamber, wherein said semipermeable membrane is permeable to one or more products of a combinatorial library
07/24/2003WO2003060026A1 Water-soluble carbamate materials
07/24/2003WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof
07/24/2003WO2003059873A1 Potassium channel modulators
07/24/2003WO2003059864A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
07/24/2003WO2003059339A1 Tricyclic-bis-enone derivatives and methods of use thereof
07/24/2003US20030139614 Catalyzing the decyclization of racemic and diastereomeric epoxides mixtures in the presence of a non-racemic, chiral catalyst; pharmaceutical synthesis
07/24/2003US20030139470 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
07/24/2003CA2472209A1 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
07/24/2003CA2467564A1 Water-soluble carbamate materials
07/23/2003EP1328509A1 Methods of producing oxazolidinone compounds
07/23/2003EP0628044B1 Therapeutic nucleosides
07/23/2003CN1431195A Synthesis of 5-(3-[exo-dicyclo [2,2,1] heptyl-2-ylidene oxy]-4-methoxy phenyl)-3,4,5,6-tetrahydropyrimidine-2 (1H) ketonic intermediate and its prepn. process
07/23/2003CN1431194A Synthesis of 5-(3-[exo-dicyclo [2,2,1] heptyl-2-ylidene oxy]-4-methoxy phenyl)-3,4,5,6-tetrahydropyrimidine-2 (1H) ketonic intermediate, and its prepn. process
07/23/2003CN1115343C Process for prepn. of (1S,4R)-or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl) -2-cyclopentene-1-methanol
07/23/2003CN1115332C Metal surface treating agent contg. polyoxyethylene alkylphenol ether derivatives
07/23/2003CN1115331C Non-ionic hydrophobic monomer and its preparing process
07/23/2003CN1115330C N-(4-carbamimido-phenyl)-phenylglycinamid derivatives
07/22/2003US6596752 Inhibitors of α4β1 mediated cell adhesion
07/22/2003US6596743 Carbamic acid derivatives
07/22/2003US6596711 GABA B receptor agonists for use in the treatment of CNS disorders, such as muscle relaxation in spinal spasticity, cardiovascular disorders, asthma, gut motility disorders such as irritable bowel syndrome and gastroesophogeal reflux
07/22/2003US6596693 Dipeptide apoptosis inhibitors and the thereof
07/17/2003WO2003057169A2 4-dedimethylamino tetracycline compounds
07/17/2003WO2003043974A3 New pharmaceutical compounds
07/17/2003US20030135066 Renin inhibitors for the treatment of hypertension and glaucoma.
07/17/2003US20030135045 Glycoprotein IIb/IIIa antagonists
07/17/2003US20030135009 Carbamylation and esterification of an aromatic polyamine, especially polymethylenepolyphenylenepolyamine, by reaction with CO, O2 and an organic hydroxyl compound in the presence of a Group VIII or lanthanide precursor and a halo compound
07/17/2003US20030134989 Forming allyloxycarbonyl-, fluorenylmethoxycarbonyl-, t-butoxycarbonyl- and benzyloxycarbonyl derivatives by aziding (chloroethoxy)ethoxyethanol, reacting with triphenyl phosphine and H2O, reacting with a chloroformate, oxidizing
07/17/2003US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
07/17/2003US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus
07/17/2003US20030133904 Sphingolipids
07/16/2003EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326834A2 2-substituted heterocyclic compounds
07/16/2003EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326711A1 Use of tin derivatives as catalysts for transforming carbamates, carbamate compositions comprising said catalyst and method for transforming carbamates
07/16/2003CN1430600A 7-and 9-carbamate, urea, thiourea, thiocarbamate and heteroaryl-amino substituted tetracycline compounds
07/16/2003CN1430599A Phenylglycine derivatives
07/16/2003CN1430596A New gamma selective retinoids
07/16/2003CN1429813A Synthetic method of 1,5-methyl naphtualene diamino formate
07/16/2003CN1114638C Alkanolamine/carbon dioxide adduct and polyurethane foam therewith
07/15/2003US6593489 Catalytic stereoselective hydrogenation
07/15/2003US6593327 Compounds and compositions as protease inhibitors
07/10/2003US20030130523 Delivers more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood; substituted phenylacetanilides containing carboxyl group(s)
07/10/2003US20030130522 Renin inhibitors; treating cardiovascular disorders and glaucoma
07/10/2003US20030130509 Process to produce 3-carbon amino alcohol salts
07/10/2003US20030130469 Multifunctional allyl carbamates and coatings therefrom
07/10/2003US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 157